Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post-liver transplant recipients.
Jain
Ashok
A
Mohanka
Ravi
R
Orloff
Mark
M
Abt
Peter
P
Ryan
Charlotte
C
Bozorgzadeh
Adel
A
D000998:Antiviral Agents / Q000494:pharmacology*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D016031:Liver Transplantation; D011183:Postoperative Complications; D000077562:Valganciclovir
D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir